Compare Gemini Space Station Inc (GEMI) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gemini Space Station Inc vs GeneDx Holdings Corp — how do they compare? Gemini Space Station Inc trades at $4.43 (market cap $579.55M), while GeneDx Holdings Corp trades at $67.75 (market cap $2.02B). The key difference: GeneDx Holdings Corp is far larger — about 3.5× Gemini Space Station Inc's market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, Gemini Space Station Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Gemini Space Station Inc for 14 Days and GeneDx Holdings Corp for 19 Days on average.
| GEMI | WGS | |
|---|---|---|
Market Cap | $579.55M | $2.02B |
Volume | 1,882,406 | 734,640 |
Sector | Financials | Health |
52-Week High | $25.41 | $167.51 |
52-Week Low | $3.54 | $34.51 |
Typical Hold Time | 14 Days | 19 Days |
Enterprise Value | $558.57M | $2.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gemini Space Station (GEMI) trades at $4.43, down 1.34% on the day, with a bearish technical outlook despite recent price surges. The company reported Q2 2026 revenue growth of 37% year-over-year but continues to post significant losses, with a net income margin of -250.13%. Recent news highlights expansion into commission-free stock trading and prediction markets, though the stock faces headwinds from earnings misses and ongoing class action lawsuits.
The investment outlook remains high-risk due to persistent unprofitability and negative cash flow from operations. While analyst consensus suggests modest upside to a $5.25 price target, the stock's viability depends on achieving profitability amid competitive pressures and regulatory scrutiny. Current valuation metrics appear stretched given the company's fundamental challenges.
GeneDx (WGS) trades at $68.50, down 0.04% with a bearish technical signal despite bullish oscillators showing oversold conditions. The company reported mixed Q2 2026 results with revenue of $114.4M beating expectations but net income margin remains negative at -23.4%. Recent developments include new product launches and positive analyst coverage with 91% buy ratings.
While analyst consensus targets $81.00 (18% upside), fundamental challenges persist with negative profitability metrics and high valuation multiples. The stock faces execution risks amid competitive genomics landscape, but operational improvements and testing volume growth provide potential catalysts for recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Gemini Space Station Inc
Gemini Space Station Inc is the parent company of the Gemini crypto ecosystem, founded by Cameron and Tyler Winklevoss. It operates as a regulated digital asset exchange and custodian, providing a platform for individuals and institutions to trade, store, and stake cryptocurrencies while serving as a trusted bridge between legacy finance and the decentralized web.
Read more on GEMI →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
